Cargando…
Quantitative cone contrast threshold testing in patients with differing pathophysiological mechanisms causing retinal diseases
BACKGROUND: Cone contrast threshold testing (CCT) provides quantitative measurements of color and contrast function to reveal changes in vision quality that are not standard endpoints in clinical trials. We utilize CCT to measure visual function in patients with multiple sclerosis (MS), age-related...
Autores principales: | White, Kayla M., Livnat, Itamar, Frambach, Caroline R., Doan, John, Mehta, Urmi V., Yuh, Clara, Palma, Anton M., Jameson, Kimberly A., Kenney, M. Cristina, Mehta, Mitul C., Boisvert, Chantal J., Crow, Wade R., Browne, Andrew W. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9893567/ https://www.ncbi.nlm.nih.gov/pubmed/36732855 http://dx.doi.org/10.1186/s40942-023-00442-3 |
Ejemplares similares
-
Quantifying Color Vision Changes Associated With Cataracts Using Cone Contrast Thresholds
por: Mehta, Urmi, et al.
Publicado: (2020) -
An atypical presentation of giant cell arteritis: Fatigable signs to anterior ischemic optic neuropathy and choroidal infarction
por: Shinbashi, Meagan, et al.
Publicado: (2023) -
Seeing invisible light: 2-photon microperimetry to measure visual function
por: Mehta, Urmi, et al.
Publicado: (2022) -
Dupilumab Induced Limbal Stem Cell Deficiency
por: Mehta, Urmi, et al.
Publicado: (2021) -
Psilocybin and Mental Health–Don't Lose Control
por: Barnby, Joseph M., et al.
Publicado: (2018)